Pfizer-BioNTech was said to have won a contract with the Philippines for the supply of the COVID-19 vaccine. It was reported that the country just signed a deal with the American multinational pharmaceutical and biotechnology company for 40 million doses of the vaccines.
The Philippines and Pfizer deal for coronavirus shots
As per Reuters, this is so far the biggest order of Pfizer COVID-19 vaccine from the Philippines. Secretary Carlito Galvez, the National Task Force chief against coronavirus, announced the deal with Pfizer on Sunday, June 20, and revealed that deliveries could be expected to begin in August.
In addition to this new order from Pfizer-BioNTech, the Philippines has now secured the delivery of 113 million doses of vaccine from five suppliers that include China's Sinovac (26 million doses), Moderna (20 million), Russia's Sputnik V (10 million) and AstraZeneca (17 million).
The vaccine supply in Manila is still limited and in some provinces, the government recorded a surge in COVID-19 cases, which complicates efforts to work up on the immunization drive. But with the upcoming Pfizer supply, officials are hoping that it will reach more people and eventually lessen the cases.
“We are very happy to report that the government and the management of Pfizer have finally concluded our negotiations, Philippine News Agency quoted Galvez as saying. “Health Secretary Francisco Duque and I signed yesterday (Saturday, June 19) the supply agreement for the biggest and most decisive deal we had for 2021.”
More vaccine jabs for the Filipinos
Galvez added that 20 million Filipinos will benefit from this Pfizer COVID-19 supply deal. The Philippines is not just waiting for deliveries from the American biotech company, but it is also expecting deliveries from the COVAX facility. In addition, a total of 16 million doses are coming from Jonhson & Johnson and Novavax as well.
Meanwhile, the Philippines will be allowing the administration of the Pfizer-BioNTech vaccines to youngsters ages 12 to 15. Their inoculation may begin later this year once the vaccine inventory expands and the priority group’s vaccinations are completed.


BlackRock-Backed Global Ports Deal Faces Uncertainty Amid Cosco Demands
California Regulator Probes Waymo Robotaxi Stalls During San Francisco Power Outage
Asian Stocks and Gold Rally as Investors Chase Year-End Gains Amid Dollar Weakness
Japan Plans $189 Billion Bond Issuance as Record Budget Signals Expansionary Fiscal Policy
Tokyo Core Inflation Stays Above BOJ Target, Strengthening Case for Further Rate Hikes
TSMC Honors Japanese Chip Equipment Makers With 2025 Supplier Awards
John Carreyrou Sues Major AI Firms Over Alleged Copyrighted Book Use in AI Training
RBA Signals Possible Interest Rate Hike in 2026 as Inflation Pressures Persist
U.S. Stocks Rally to Record Highs as AI Rebound Fuels Holiday-Shortened Session
Eli Lilly and Novo Nordisk Battle for India’s Fast-Growing Obesity Drug Market
Texas App Store Age Verification Law Blocked by Federal Judge in First Amendment Ruling
South Korean Court Clears Korea Zinc’s $7.4 Billion U.S. Smelter Project, Shares Surge
IMF Reaches Staff-Level Agreement With Egypt, Opening Path to $3.8 Billion in Funding
Oil Prices Edge Higher as Strong U.S. Growth and Supply Risks Support Market
Nvidia to Acquire Groq in $20 Billion Deal to Boost AI Chip Dominance
Oil Prices Hold Steady in Asia as Geopolitical Tensions Support Market 



